Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain)

Abstract

This is the first population-based study on the epidemiology of JIA in Catalonia. Incidence and prevalence rates are lower than those reported for several areas in Nordic countries of Europe. Oligoarthritis was the most common subtype.

The pattern of juvenile idiopathic arthritis; a retrospective Egyptian study

“…15,20 On contrary, to many studies the numbers of male patients were higher than the females. [11][12][13][14][15][16] However, our results matched Ozdogan et al 21 and El-hemiari et al 22 who reported male predominance.…”

“…Similar to previous studies mainly in USA, Canada, Turkey, France and Spain oligoarticular JIA was found to be the most common clinical pattern. 11,12 On contrary to Saudi Arabia study 13 , systemic onset was the most common type while a Kuwaiti study conducted by Khuffash 14 15,16 Most of the demographic data of the studied groups were consistent with results of previous national and international studies as the mean age of onset of the disease was (6.1±2.8 yr.), which was close to that reported in Saudi Arabia (6± 2 yr.) by Bahabri et al 12 and Mengual et al 17 in Spain (5.8±2.2 yr.). Meanwhile, age was lower than that reported by Ruperto et al 18 (8±3yr) and a cohort study at Taiwan (9.1y).…”

Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case–Control Study

“…24 The incidence (overall and genderspecific) of JIA in our cohort was similar to earlier published estimates from other western European countries using current classification criteria. 46,47 Secondary case definitions designed to increase the specificity of JIA diagnoses yielded similar results. Finally, multiple sensitivity analyses were consistent and robust to a wide range of assumptions.…”

Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age

“…Worldwide incidence and prevalence varies from 1.9 to 22.6/100.000 childrenyear and from 10 to 148.1/100.000 children, respectively. [1][2][3][4][5][6]. Both disability and reduced quality of life in untreated patients have been described [7][8][9][10][11].…”